Upcoming Webinar:
Evidence-Driven Target Discovery: Knowledge Graphs That Reconstruct Disease-State Transitions
Register Now
Technology
Tech - Polly
Polly is Elucidata’s Multi-Modal Agentic Stack for Target Validation. Polly modules come together to form solutions to help you in various stages of target ID
Polly Modules
Data Concierge
We filter out noise from existing scientific literature.
Polly Scout
AI-powered discovery and prioritization of public biomedical datasets.
Knowledge Graph
Connects genes, diseases, drugs, and pathways in one queryable graph.
Atlas
Harmonizes multi-modal biomedical data into ML-ready formats.
Security & Compliance
Data governance and access controls for regulated R&D.
Polly Xtract
Turns unstructured documents into structured, analysis-ready data.
Co-Scientist
Agentic discovery workflows run in natural language over Polly data.
Deploy Your Data Anywhere
Cloud, on-premise, or hybrid deployment for your stack.
Data Modalities
Data on Polly
Single-cell RNA-seq
Bulk RNA-seq
Microarray
Proteomics
Spatial Transcriptomics
Data on Polly
Single-cell RNA-seq
Bulk RNA-seq
Microarray
Proteomics
Spatial Transcriptomics
Single cell CITE-seq
EHR
Assay Data
Single cell ATAC-seq
Whole Slide Imaging
Target Identification
Rapidly identify and validate targets with harmonized multi-omics data.
Biomarker Discovery
Predict diagnostic or prognostic biomarkers by analyzing multi-omics data.
Meta-analysis
Integrate expression data to extract molecular signatures.
Signature Exploration
Identify indications related to a gene signature, or find drugs that reverse a disease signature.
Patient Stratification
Train ML Classifiers on Harmonized Data to segment patient cohorts.
Target Identification
Rapidly identify and validate targets with harmonized multi-omics data.
Biomarker Discovery
Predict diagnostic or prognostic biomarkers by analyzing multi-omics data.
Meta-analysis
Integrate expression data to extract molecular signatures.
Signature Exploration
Identify indications related to a gene signature, or find drugs that reverse a disease signature.
Patient Stratification
Train ML Classifiers on Harmonized Data to segment patient cohorts.
Foundation Models
AI-ready data and scalable harmonization for faster and more accurate predictions
Quick Links
case study
Data-Centric Cross-Species Target Discovery...
Blog
How In Silico Perturbation Prediction Can Help De-Risk Target Discovery
Whitepaper
Predicting Novel Crosstalks in Oncology Using evidence-rich knowledge graphs
Who We Serve
Who We Serve?
Discover tailored solutions for life sciences based on your unique requirements - Achieve faster R&D outcomes, unlock cost and time efficiencies, break data silos or scale cloud infrastructure for growth!
Early Stage R&D
Harmonized data with a full suite of IND-enabling solutions for accelerating R&D.
Precision Medicine Diagnostics
Scalable and secure data processing cloud infrastructure to set up your diagnostic R&D workflows for commercial growth and global expansion.
Research Informatics
End-to-end data ecosystem aided with technology, processes and experts to break data silos and drive successful AI initiatives in BioPharma.
Translational Research
Translational teams bridge the gap between scientific discoveries and clinical applications, accelerating the journey from bench to bedside.
Early Stage R&D
Harmonized data with a full suite of IND-enabling solutions for accelerating R&D.
Precision Medicine Diagnostics
Scalable and secure data processing cloud infrastructure to set up your diagnostic R&D workflows for commercial growth and global expansion.
Research Informatics
End-to-end data ecosystem aided with technology, processes and experts to break data silos and drive successful AI initiatives in BioPharma.
Translational Research
Translational teams bridge the gap between scientific discoveries and clinical applications, accelerating the journey from bench to bedside.
Quick Links
Blog
Building Biomedical Data & ML-ops Platform: From Collection to Discoveries
CASE STUDY
Optimizing Diagnostics: Elucidata Doubles (2X) Sample to Report Speed
Solutions
Solutions
Elucidata co-builds a program-specific target decision solution that connects evidence & surfaces targets your team can act on.
About Us
Careers
Mission - Vision
Press & Media
Team
Data Harmonization
Normalize multi-omics datasets across sources into one analysis-ready layer.
Data Concierge
Dedicated team that ingests, curates, and maintains your biomedical data end to end.
Metadata Curation
Ontology-backed annotation that makes your datasets structured and AI-ready.
Data Quality Assessments
Audits that surface data gaps and quality issues before they affect analysis.
Bioinformatics Pipelines
Program-specific pipelines for transcriptomics, proteomics, and genomics workflows.
Custom Apps & Dashboards
Custom decision interfaces and dashboards co-built with your team on Polly.
Data Harmonization
Normalize multi-omics datasets across sources into one analysis-ready layer.
Data Concierge
Dedicated team that ingests, curates, and maintains your biomedical data end to end.
Metadata Curation
Ontology-backed annotation that makes your datasets structured and AI-ready.
Data Quality Assessments
Audits that surface data gaps and quality issues before they affect analysis.
Bioinformatics Pipelines
Program-specific pipelines for transcriptomics, proteomics, and genomics workflows.
Custom Apps & Dashboards
Custom decision interfaces and dashboards co-built with your team on Polly.
Quick Links
case study
Data-Centric Cross-Species Target Discovery...
R&D
Advance Precision Diagnostics With Polly
Blog
How In Silico Perturbation Prediction Can Help De-Risk Target Discovery
Company
Company
At Elucidata, we are committed to building a TechBio company for the future that will transform drug discovery by integrating different forms of biomedical data.
About Us
Careers
Mission - Vision
Press & Media
Team
Leadership
Customers
Our Mission
Publications
Team
Careers
Press & Media
Quick Links
Webinar
Evidence-Driven Target Discovery: Knowledge Graphs That Reconstruct Disease-State Transitions
Blog
How In Silico Perturbation Prediction Can Help De-Risk Target Discovery
Resources
Elucidata Resources
Explore our product updates, industry insights and customer stories through our blogs, case-studies, webinars, white papers, videos and more.
Blogs
Case Studies
Datasets at a Glance
Glossary
Solution Briefs
Webinars
Whitepapers
Blogs
Case Studies
Datasets at a Glance
Glossary
Solution Briefs
Webinars
Whitepapers
Events
Data Modalities
Assets
Drug Target
Turing Test for Drug Discovery
Quick Links
Whitepaper
Predicting Novel Crosstalks in Oncology Using evidence-rich knowledge graphs
Solution Brief
Faster Insights on Omics Data Signatures with Polly Discover
dataset roundup
Multi-modal Obesity Datasets For Target ID and Validation
Resources
Spotlight
Upcoming
Events
Login
Request Demo
Talk to Our expert
[Upcoming Webinar]
Scaling High-Quality Data Processing: Achieve 4x Cost Reduction for Foundation Models
Register Now->
Reserve Your Seat
Trending Blogs
How Agentic AI is Rewriting the Rules of Flow Cytometry: An approach towards Automated Gating in AML.
·
May 19, 2026
Target Discovery and Independent Orthogonal Validation for Small Cell Lung Carcinoma
·
March 9, 2026
Polly
Polly Scout: Find the Fastest Path to Right Public Biomedical Data
·
February 25, 2026
AI Labs
CellAtria vs Polly BioAgent: Why Autonomous AI Beats Rigid Pipelines?
Kewal Mishra
·
February 9, 2026
Data Science & Machine Learning
Challenges with Diagnostics Data Processing Pipelines
Deepthi Das
·
May 15, 2024
How Agentic AI is Rewriting the Rules of Flow Cytometry: An approach towards Automated Gating in AML.
Max 10 Mins Read
01/
05
Target Discovery and Independent Orthogonal Validation for Small Cell Lung Carcinoma
Max 10 Mins Read
02/
05
Polly
Polly Scout: Find the Fastest Path to Right Public Biomedical Data
Max 10 Mins Read
03/
05
AI Labs
CellAtria vs Polly BioAgent: Why Autonomous AI Beats Rigid Pipelines?
Kewal Mishra
04/
05
Data Science & Machine Learning
Challenges with Diagnostics Data Processing Pipelines
Deepthi Das
05/
05
All Blogs
AI Labs
CDMO
Company & Culture
Data Analysis and Management
Data Quality & Compliance
Data Science & Machine Learning
FAIR Data
Industry Features
Others
Polly
Product & Engineering
Top Drug Targets
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
CDMO
Spreadsheet Hell Is Still the Default in CDMO Data Handoffs, and It's Costing You More Than Time
·
June 17, 2026
Prateeksha Muddemmanavar
Max 10 Mins Read
Why Workflow Automation Matters for Antibody Development and Biologics R&D
·
May 25, 2026
Max 10 Mins Read
How Agentic AI is Rewriting the Rules of Flow Cytometry: An approach towards Automated Gating in AML.
·
May 19, 2026
Max 10 Mins Read
Others
How Whole Genome Sequencing Helps Researchers Unlock Deeper Biological Insights
·
May 18, 2026
Max 10 Mins Read
Whole Exome Sequencing: Accelerating Precision Diagnostics with Variant Stores and Multimodal Data
·
May 15, 2026
Max 10 Mins Read
Why Target Discovery Demands Mechanistic Context For Better Therapeutic Decisions
·
May 13, 2026
Max 10 Mins Read
Load More
Other Resources
Case Studies
Webinars
Whitepapers
Documentation
Dataset Roundup
Solution Briefs
CDMO
Spreadsheet Hell Is Still the Default in CDMO Data Handoffs, and It's Costing You More Than Time
Prateeksha Muddemmanavar
Why Workflow Automation Matters for Antibody Development and Biologics R&D
How Agentic AI is Rewriting the Rules of Flow Cytometry: An approach towards Automated Gating in AML.
Others
How Whole Genome Sequencing Helps Researchers Unlock Deeper Biological Insights
Whole Exome Sequencing: Accelerating Precision Diagnostics with Variant Stores and Multimodal Data
Why Target Discovery Demands Mechanistic Context For Better Therapeutic Decisions
Advancing Precision Medicine in Complex Diseases by AI-driven Disease Subtyping
How Knowledge Graphs Are Accelerating Drug Repurposing and Indication Expansion
How AI Models are transforming target discovery and scaling CRISPR screens
Load More
CDMO
Spreadsheet Hell Is Still the Default in CDMO Data Handoffs, and It's Costing You More Than Time
Prateeksha Muddemmanavar
Why Workflow Automation Matters for Antibody Development and Biologics R&D
How Agentic AI is Rewriting the Rules of Flow Cytometry: An approach towards Automated Gating in AML.
Others
How Whole Genome Sequencing Helps Researchers Unlock Deeper Biological Insights
Whole Exome Sequencing: Accelerating Precision Diagnostics with Variant Stores and Multimodal Data
Why Target Discovery Demands Mechanistic Context For Better Therapeutic Decisions
Book A Demo
Enable R&D by Harnessing ML’s Potential for Biological Data.
Thank you for reaching out!
Our team will get in touch with you over email within next 24-48hrs.
Oops! Something went wrong while submitting the form.
Other Resources
Case Studies
Dataset Roundup
Documentation
Glossary
Solution Briefs
Webinars
Whitepapers
Advancing Precision Medicine in Complex Diseases by AI-driven Disease Subtyping
How Knowledge Graphs Are Accelerating Drug Repurposing and Indication Expansion
How AI Models are transforming target discovery and scaling CRISPR screens
Why Life Sciences Organizations Are Moving Beyond Static Genomic Storage
How AI is Mastering Perturbation Prediction
How Simulating Perturbations Can Help Fix Toxicity Failures in Drug Discovery
Load More
Blog Categories
CDMO
Top Drug Targets
AI Labs
Data Analysis and Management
Data Quality & Compliance
Industry Features
Product & Engineering
Data Science & Machine Learning
Company & Culture
FAIR Data
Others
Polly
Subscribe
to Our Newsletter
Get the latest news, industry insights, and updates delivered directly to your inbox.
Thanks for showing interest!
Oops! Something went wrong while submitting the form.
Request Demo
%20(1).svg)
.svg)
.svg)
.svg)
.svg)
%201%20(1).svg)
%20(1).svg)
%201%20(1).svg)
.svg)
%201.svg){kind=icon}
%20(1).svg){kind=avatar}
%20(1).svg)
%201%20(1).svg){kind=icon}
.png)
